DEF 14A

Company

Ginkgo Bioworks Holdings, Inc.

Filed

July 5, 2024

Period of Report

August 14, 2024

Accession Number

0001628280-24-031299

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →